Disorders with eosinophilia, treatment of hypereosinophilic syndrome;Eosinophiliával járó kóképek. A hypereosinophil szindróma jellemzoi és kezelési lehetoségei

Orvosi Hetilap

Volumn 146, Issue 18 SUPPL.1, 2005, Pages 911-916

  Borbényi, Zita ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE   (Hungary)

Author keywords

Clonality; Eosinophil cells; Imatinib mesylate

Indexed keywords

ALPHA INTERFERON; HYBRID PROTEIN; HYDROXYUREA; IMATINIB; PLATELET DERIVED GROWTH FACTOR A; PROTEIN FIP1L1; STEROID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1 PDGFRA FUSION PROTEIN, HUMAN; FIP1L1-PDGFRA FUSION PROTEIN, HUMAN; GLUCOCORTICOID; ONCOPROTEIN; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

CANCER CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EOSINOPHILIA; HEMATOPOIETIC CELL; HUMAN; HYPEREOSINOPHILIC SYNDROME; REVIEW; DECISION TREE; DRUG ANTAGONISM; METABOLISM; MYELOPROLIFERATIVE DISORDER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DECISION TREES; EOSINOPHILIA; GLUCOCORTICOIDS; HUMANS; HYDROXYUREA; HYPEREOSINOPHILIC SYNDROME; INTERFERON-ALPHA; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 23844497858     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Akiyama, Y., Shimizu, A., Kimura, A. és mtsai: Successful treatment of hypererosinophlic syndroma with cyclosporin and steroids. Nihon Kyobu Shikkan Gakkai Zasshi, 1997, 35, 541-545.
2. Apperley, J. F., Gardembas, M., Melo, J. V. és mtsai: Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N. Engl. J. Med., 2002, 347, 481-487.
3. Ault, P., Cortes, J., Koller, C. és mtsai: Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leuk. Res., 2002, 26, 881-884.
4. Bain, B.: Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Br. J. Hem., 1996, 95, 2-9.
5. Bain, B., Pierre, R., Imbert, M. és mtsai: Chronic eosinophilic leukemia and the hypereosinophilic syndrome. In World Health Organization classification of tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Szerk.: Jaffe, E. S., Harris, N. L., Stein, H. és mtsai. IARC Press, Lyon. 2001, 29-31. old.
6. Balestra, B., Pedrazzi, P., Regli, F.: Recurrent subacute encephalopathy in the framework of idiopathic hypererosinophilic syndrome. D. Med. Wochsch., 1999, 124, 321-324.
7. Bigoni, R., Cunes, A. Roberti, M. G. és mtsai: Cytogenetic and molecular cytogenetic characterisation of 6 new cases of idiopathic hypereosinophilic syndrome. Haematology., 2000, 85, 486-491.
8. Bridgen, M. L.: A practical workup for eosinophilia. You can investigate the most likely causes right in your office. Postgrad. Med., 1999, 105, 207-210.
9. Brito-Babapulle, F.: Clonal eosinophilic disorders and the hypererosinophilic syndrome. Blood Rev., 1997, 11, 129-145.
10. Brito-Babapulle, F.: The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br. J. Hematol., 2003, 121, 203-223.
11. Cha, S. H., Park, C. M., Ca, I. H. és mtsai: Hepatic involvement in hypereosinophilic syndrome; value of portal venous phase imaging. Abd. Imag., 1998, 23, 154-157.
12. Chang H. W., Leong, K. H., Koh, D. R. és mtsai: Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood, 1999, 93, 1651-1657.
13. Chockalingam, A., Jalil, A., Shadduck, R. K. és mtsai: Allogenic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction. Marrow Transpl., 1999, 23, 1093-1094.
14. Choi, Y. J., Lee, J. D., Yang, K. H. és mtsai: Immunotactoid glomerulopathy associated with idiopathic hypereosinophilic syndrome. Am. J. Nephrol., 1998, 18, 337-343.
15. Chusid, M. J., Dale, D. C.: Eosinophilic leukaemia. Remission with vincristine and hydroxyurea. Am. J. of Med., 1975, 59, 297-300.
16. Cools, J., DeAngelo, D. J., Gotlib J. és mtsai: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med., 2003, 348, 1201-1214.
17. Cools, J., Stover, E. H., Wlodarska, I. és mtsai: A FIP1L1-PDGFR-a kináz szerepe hypereosinophil szindrómában és krónikus eosinophil leukaemiában. Curr. Opin. Hematol., 2003, 11, 51-57. (Magyar változat)
18. De Cock, C., Lemaitre, J., Deuvaert, F. E.: Loeffler endomycarditis: a clinical presentation as a right ventricular tumour. Journal of Heart Valve Disease, 1998, 7, 668-671.
19. Diaz, F., Collazos, J.: Reversible cerebellar involvement in the idiopathic hypererosinophil syndrome. Postgrad. Med. J., 1999, 75, 477-479.
20. Doherty, E. A.: Fluctuating MRI findings in a patient with central nervous system idiopathic hypereosinophlilic syndrome: a case report. J. Neuroim., 1997, 7, 192-195.
21. Donhuijsen, K., Haedicke, C., Hattenberger, S. és mtsai: Granulocyte-macrohage colony-stimulating factor related eosinophilia and Loeffler's endocarditis. Blood, 1992, 79, 2798-2801.
22. Doorduijn, J. K., van Lom, K., Lowenberg, B.: Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years. Br. J. Haematol., 1996, 95, 531-534.
23. Duell, T., Mittermuller, J., Schmetzer, H. M. és mtsai: Chronic myeloid leukaemia associated hypereosinophilic syndrome with a clonal t(4:7)(q11:q32). Cancer. Gen. Cytogen., 1997, 94, 91-94.
24. Forrest, D. L., Horsman, D. E., Jensen, C. L. és mtsai: Myelodysplastic syndrome with hypereosinophilia and a non random chromosomal abnormality dic (1;7): confirmation of eosinophil clonal involvement by fluorescence in situ hybridization. Cancer Gen. Cytogen., 1998, 107, 65-68.
25. Gabbas, A. G., Li, C. F.: ANLL with eosinophilic differentiation. Am. J. Haemat., 1986, 21, 29-38.
26. Genereau, T.: Hypereosinophilic reactions in cancer. La Rev. Du Pratic., 2000, 50, 612-615.
27. Gleich, G. J., Leiferman, K. M., Pardanani, A. és mtsai: Treatment of hyperoesinophilic syndrome with imatinib mesylate. Lancet, 2002, 359, 1577-1578.
28. Gotic, M., Radosevic-Radojkovic, N., Ludoski, M. és mtsai: Eosinophilic leukaemia with chromosomal aberration t(5:12) (31:q13). Br. J. Haematol., 1994, 87, 68-72.
29. Gotlib, J., Cools, J., Malone, J. M. és mtsai: The FIP1L1-PDGFRa fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implication for diagnosis, classification and management. Blood, 2004, 103, 2879-2891.
30. Hayashi, S., Idobe, M., Okubo, Y. és mtsai: Improvement of eosinophilic heart disease after steroid therapy: succesful demonstration by endomyocardial biopsied specimens. Heart. Vess., 1999, 14, 104-571.
31. Hogan, T. F., Koss, W., Murgo, A. J. és mtsai: Acute lymphoblastic leukaemia with chromosomal 5:14 translocation and hypereosinophilia: case report and literature review. J. Clin. Onc., 1987, 5, 382-390.
32. Inhorn, R. C., Aster, J. C., Roach, S. A. és mtsai: A syndrome of lymphoblastic lymphoma, eosinophilia and myeloid hyperplasia/malig- nancy associated with t(8:13)(p11:q11): description of a distinctive pathological entity. Blood, 1995, 85, 1881-1887.
33. Ito, T., Harada, K., Takada, G.: An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventrivular diastolic dysfunction observed by echocardiography. Heart Vess., 1998, 3, 302-305.
34. Jani, K., Kempski, H. M., Reeves, B. R.: A case of myelodysplasia with eosinophilia having a translocation t(5:12)(q31:q13). Br. J. Haematol., 1994, 87, 57-60.
35. Johkoh, T., Muller, N. L., Akira, M. és mtsai: Eosinophilic lung diseases: diagnostic accuracy of thin section CT is 111 patients. Radiol., 2000, 216, 773-780.
36. Kataoka, H., Konishi, T., Nagano, T. és mtsai: A case of idiopathic hypereosinophilic syndrome with special reference to mental disorders and brain images. Rinsho-Shinkeigaku, 1997, 37, 996-1000.
37. Kwong, Y. L., Chan, L. C.: Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br. J. Haematol., 1994, 88, 389-391.
38. Longley, B. J., Tyrell, L., Lu, S. Z. és mtsai: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality on a human mast cell neoplasm. Nature Gen., 1996, 12, 312-314.
39. Luciano, L., Catalano, L., Sarrantonio, C. és mtsai: Alpha IFN induced haematologic and cytogenetic remission in chronic eosinopholic leukaemia with t(1:5), Haematol., 1999, 84, 651-653.
40. Luppi, M., Marasca, R., Morselli, M. és mtsai: Clonal nature of hypereosinophilic syndrome. Blood, 1994, 84, 349-350.
41. Ma, S. K., Kwong, Y. L., Shek, T. W. és mtsai: The role of trisomy 8 in the pathogeneis of chronic eosinophilic leukaemia. Human Pathol., 1999, 30, 864-868.
42. McElroy, E. A., Phyliky, R. L., Li, C. Y.: Systemic mast cell disease associated with the hypereosinophillic syndrome. Mayo Clinic Proc., 1998, 73, 47-50.
43. Matsushima, T., Murakami, H., Sawamura, M. és mtsai: Myelodyplastic syndrome with eosinophilia bone marrow. Br. J. Haematol., 1993, 84, 636-638.
44. Means-Markwell, M., Burgess, T., de Keratry D. és mtsai: Brief Report. Eosinophilia with aberrant T cells and elevated serum levels of interleukin 2 and interleukin 15. N. Engl. J. Med., 2000, 342, 1568-1571.
45. Moore, P. M., Harley, J. B., Fauci, A. S.: Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Int. Med., 1985, 102, 109-114.
46. O'Seha, J. J., Jaffe, E. S., Lane, H. C. és mtsai: Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis: clinical pathologic and immunologic features. Am. J. of Med., 1987, 82, 539-545.
47. Oliver, J. W., Deal, I., Morgan, D. L. és mtsai: Chronic eosinophilic leukaemia and hypereosinophilic syndromes. Proposal for classification, literature review and report of a case with a unique chromosomal abnormality. Cancer Gen. Cytogen., 1998, 107, 111-117.
48. Pardanani, A., Ketterling, R. P., Brockman, S. R. és mtsai: CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib therapy. Blood, 2003, 102, 3093-3096.
49. Sanderson, C. J: Interleukin 5, eosinophilis and disease. Blood, 1992, 79, 3101-3109.
50. Simon, H. U., Plotz, S. G., Dummer, R. és mtsai: Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N. Engl. J. Med., 1999, 341, 1112-1120.